Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer
Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization...
Covered in this story
What has happened since
- Waters Corporation is up 8.0% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Waters Corporation
- TD Cowen: $400 → $475 by Aug 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $WAT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Waters Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.